Insider Shareholders with Direct Ownership of Reata Pharmaceuticals Inc (RETA)
This section provides a comprehensive overview of the insiders with direct ownership of Reata Pharmaceuticals Inc (RETA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
REATA PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Abb Vie Inc.
> 10% Shareholder |
1,505,241 | 450,000 | 1,190,473 $0 | 2 |
Mar 28, 2017
Reduced 27.43%
|
|
James Warren Huff
Chief Executive Officer |
206,245 | 279,137 | 122,480 $0 | 7 |
Jul 06, 2023
Added 37.2%
|
|
Samina Khan
SVP, Chief Medical Officer |
36,756 | 32,414 | 39,491 $0 | 7 |
May 16, 2023
Reduced 0.88%
|
|
Elaine Castellanos
VP, Chief Accounting Officer |
23,500 | 24,100 | 14,546 $0 | 9 |
Jun 09, 2021
Reduced 3.67%
|
| 0 | 25,004 | 4,787 $0 | 1 |
Jun 08, 2022
Added 50.0%
|
|
|
William Rose
Director |
0 | 31,413 | 3,330 $0 | 1 |
Jun 08, 2022
Added 50.0%
|
|
Steven Ryder
Director |
10,907 | 10,907 | 0 $0 | 3 |
Sep 26, 2023
Reduced 100.0%
|
|
Michael D Wortley
Chief Legal Officer |
106,229 | 106,229 | 0 $0 | 12 |
Sep 26, 2023
Reduced 100.0%
|
|
Shamim Ruff
Director |
21,334 | 21,334 | 0 $0 | 8 |
Sep 26, 2023
Reduced 100.0%
|
|
Christy J. Oliger
Director |
5,565 | 5,565 | 0 $0 | 3 |
Sep 26, 2023
Reduced 100.0%
|
|
William D. Mc Clellan Jr.
Director |
19,017 | 19,017 | 0 $0 | 10 |
Sep 26, 2023
Reduced 100.0%
|
|
Martin Edwards
Director |
6,116 | 6,116 | 0 $0 | 4 |
Sep 26, 2023
Reduced 100.0%
|
|
Bhaskar Anand
SVP, Chief Accounting Officer |
25,312 | 29,312 | 0 $0 | 13 |
Sep 26, 2023
Reduced 100.0%
|
|
Dawn Carter Bir
Chief Commercial Officer |
244,800 | 244,800 | 0 $0 | 18 |
Sep 26, 2023
Reduced 100.0%
|
|
Colin John Meyer
Chief Innovation Officer |
198,149 | 295,149 | 0 $0 | 21 |
Sep 26, 2023
Reduced 100.0%
|
|
Manmeet Singh Soni
COO, CFO and President |
245,513 | 248,513 | 0 $0 | 16 |
Sep 26, 2023
Reduced 100.0%
|
|
Andrea Loewen
SVP, Global Regulatory Affairs |
26,756 | 59,612 | 0 $0 | 10 |
Sep 26, 2023
Reduced 100.0%
|
|
Rajiv Patni
EVP, Chief R&D Officer |
45,000 | 45,000 | 0 $0 | 2 |
Sep 26, 2023
Reduced 100.0%
|